Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions.

Sterling Johnson joins Ethics Talk to discuss his article, coauthored with Dr Kimberly L. Sue: "Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies.”

Dr Brady J. Heward joins Ethics Talk to discuss his article, coauthored with Drs Amy M. Yule and Peter R. Jackson: “How Should Harm Reduction Strategies Differ for Adolescents and Adults?”

Dr Kelly Gillespie joins Ethics Talk to discuss her article, coauthored with Dr Taleed El-Sabawi: “When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond?”

Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population.

Many marginalized patients with disabilities reside in nursing homes and are more susceptible to antibiotic under- and overtreatment.

Dr Katie Savin joins Ethics Talk to discuss their article, coauthored with Drs Laura Guidry-Grimes and Olivia S. Kates: “What Does Disability Justice Require of Antimicrobial Stewardship?”

Antimicrobial resistance is a global threat that inequitably affects minoritized populations, including Black, Latinx, and Indigenous people, especially in carceral settings.

This article summarizes how the AMA Code can be applied to antimicrobial resistance.

Use of body mass index as a health care metric is controversial, especially in candidacy assessments for gender-affirming surgery.